Fludarabine and fatigue Patient Reports February 12, 2012

Fludarabine Side Effects Report #5409641-6
Fludarabine side effect was reported by a Health Professional from UNITED STATES on Aug 07, 2007. Female patient was diagnosed with stem cell transplant and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: cryptogenic organising pneumonia, fatigue. Fludarabine dosage: 54 MG DAILY IV DRIP. During the same period patient was treated with THIOTEPA. Patient died on 08/02/2007.

Fludarabine Side Effects Report #5238266-0
Fludarabine side effect was reported by a Pharmacist from UNITED STATES on Feb 09, 2007. Female patient, 83 years of age, weighting 140.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: chest discomfort, dyspnoea, erythema, fatigue, oedema, pain in extremity, weight decreased. Fludarabine dosage: 42 MG QD FOR 5 DAYS IV DRIP. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #4907304-4
Fludarabine side effect was reported by a Pharmacist from UNITED STATES on Feb 08, 2006. Male patient, 58 years of age, weighting 212.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: body temperature increased, fatigue, oedema peripheral, pancytopenia, productive cough. Fludarabine dosage: 55 MG IV DAILY X 5 DAYS. During the same period patient was treated with RITUXIMAB, SENNA, PROCHLORPERAZINE, FILGRASTIM. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5143071-X
Fludarabine side effect was reported by a Health Professional from UNITED STATES on Nov 01, 2006. Female patient, weighting 121.0 lb, was diagnosed with haematopoietic stem cell mobilisation, stem cell transplant and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: asthenia, blood test abnormal, fatigue, haematocrit decreased, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Fludarabine dosage: 48 MG DAILY IV DRIP. During the same period patient was treated with CAMPATH, MELPHALAN. Patient was hospitalized. Patient recovered.


Fludarabine Side Effects Report #6027074-9
Fludarabine side effect was reported by a Physician from UNITED KINGDOM on Dec 29, 2008. Female patient, 50 years of age, was diagnosed with gastric cancer and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: epistaxis, fatigue, haemorrhage intracranial, hypotension, liver function test abnormal, lower respiratory tract infection, lung consolidation, mobility decreased, muscular weakness. Fludarabine dosage: unknown. During the same period patient was treated with MFEZ T CELLS, PROLEUKIN, INTRAVENOUS FLUID SUPPORT WITH GELOFUSION. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #6031674-X
Fludarabine side effect was reported by a Physician from UNITED KINGDOM on Jan 06, 2009. Female patient, 50 years of age, was diagnosed with gastric cancer and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: epistaxis, fatigue, haemorrhage intracranial, hypotension, liver function test abnormal, lower respiratory tract infection, lung consolidation, mobility decreased, muscular weakness. Fludarabine dosage: unknown. During the same period patient was treated with MFEZ T CELLS, PROLEUKIN, INTRAVENOUS FLUID SUPPORT WITH GELOFUSION. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #6050553-5
Fludarabine side effect was reported by a Physician from UNITED KINGDOM on Jan 20, 2009. Female patient, 50 years of age, was diagnosed with gastric cancer and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: epistaxis, fatigue, haemorrhage intracranial, hypotension, liver function test abnormal, lower respiratory tract infection, lung consolidation, mobility decreased, muscular weakness. Fludarabine dosage: unknown. During the same period patient was treated with MFEZ T CELLS, PROLEUKIN, INTRAVENOUS FLUID SUPPORT WITH GELOFUSION. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #6061261-9
Fludarabine side effect was reported by a Physician from UNITED KINGDOM on Jan 28, 2009. Female patient, 50 years of age, was diagnosed with gastric cancer and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: epistaxis, fatigue, haemorrhage intracranial, hypotension, liver function test abnormal, lower respiratory tract infection, lung consolidation, mobility decreased, muscular weakness. Fludarabine dosage: unknown. During the same period patient was treated with MFEZ T CELLS, PROLEUKIN, INTRAVENOUS FLUID SUPPORT WITH GELOFUSION. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5131125-3
Fludarabine side effect was reported by a Health Professional from GERMANY on Sept 29, 2006. Male patient, 73 years of age, weighting 218.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: anaemia, fatigue, leukopenia, renal failure. Fludarabine dosage: unknown. Patient recovered.


Fludarabine Side Effects Report #5150315-7
Fludarabine side effect was reported by a Health Professional from GERMANY on Oct 23, 2006. Male patient, 73 years of age, weighting 218.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, fatigue, hepatomegaly, leukopenia, renal failure, splenomegaly. Fludarabine dosage: 25 MG/M2, INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, METOPROLOL SUCCINATE, METFORMIN. Patient recovered.

Fludarabine Side Effects Report #5949763-4
Fludarabine side effect was reported by a Physician from NETHERLANDS on Nov 03, 2008. Female patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: disease progression, fatigue, pyrexia, urinary retention. Fludarabine dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5973415-8
Fludarabine side effect was reported by a Physician from NETHERLANDS on Nov 21, 2008. Female patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: fatigue, pyrexia, urinary retention. Fludarabine dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #6101769-0
Fludarabine side effect was reported by a Consumer or non-health professional from NETHERLANDS on Feb 12, 2009. Female patient, 69 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: fatigue, pyrexia, urinary retention. Fludarabine dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5767470-8
Fludarabine side effect was reported by a Health Professional from UNITED STATES on June 11, 2008. Female patient, 57 years of age, weighting 183.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: anorexia, asthenia, bacterial infection , blood culture positive, dyspnoea, fatigue, tremor. Fludarabine dosage: 44.5 MG DAY1-5 Q 28 DAYS IV DRIP. During the same period patient was treated with RITUXIMAB, ACETAMINOPHIN, BENADRYL, HYDROCORTISONE, ACYCLOVIR, BACTRIM, ALLOPURINOL. Patient was hospitalized. Patient recovered.


Fludarabine Side Effects Report #4624413-8
Fludarabine side effect was reported by a Health Professional from on Mar 30, 2005. Female patient, 47 years of age, weighting 189.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: blood bilirubin abnormal, eye disorder, fatigue, graft versus host disease, hypoxia, pleural effusion, pneumonia , pyrexia, skin disorder. Fludarabine dosage: 85MG QD INTRAVENOU. During the same period patient was treated with CYTOXAN, ACYCLOVIR, CIPROFLOXACIN, VANCOMYCIN, ABELCET, HYDROCORTISONE, GLUTAMINE, CAROFATE. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5341714-9
Fludarabine side effect was reported by a Health Professional from UNITED STATES on May 29, 2007. Male patient was diagnosed with chronic lymphocytic leukaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, fatigue. Fludarabine dosage: 20MG/M2 IV X 3 DAYS Q28 DAYS. During the same period patient was treated with CYCLOPHOSPHAMIDE, IMMUNE GLOBULIN INTRAVENOUS, CAPOTEN, LOPRESSOR, BACTRIM DS, ACYCLOVIR, ASPIRIN. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #4604927-7
Fludarabine side effect was reported by a Health Professional from on Mar 10, 2005. Female patient, 64 years of age, was diagnosed with bone marrow conditioning regimen, stem cell transplant and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: bacterial infection , crackles lung, dizziness , failure to thrive, fatigue, neutropenia, productive cough. Fludarabine dosage: 57 MG IV QD. During the same period patient was treated with MELPHALAN, CAMPATH, PREDNISONE, TOPROL, NORVASC, AVELOX, CYCLOSPORINE, ALBUTEROL. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5802475-X
Fludarabine side effect was reported by a Health Professional from ITALY on June 20, 2008. Male patient, 51 years of age, was diagnosed with bone marrow conditioning regimen, b-cell lymphoma, prophylaxis against graft versus host disease and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, autoimmune hepatitis, blood alkaline phosphatase increased, fatigue, hepatomegaly, jaundice , liver injury, pulmonary sepsis. Fludarabine dosage: unknown. During the same period patient was treated with PREDNISONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, RITUXIMAB, THIOTEPA, CYCLOSPORINE, METHOTREXATE. Patient died on 01/01/2005.

Fludarabine Side Effects Report #4939173-0
Fludarabine side effect was reported by a Health Professional from UNITED STATES on Mar 09, 2006. Male patient, weighting 187.2 lb, was diagnosed with aplastic anaemia and was treated with Fludarabine. After drug was administered, patient experienced the following side effects: dyspnoea exertional, fatigue, haematocrit decreased, haemoglobin decreased, lung neoplasm, oxygen saturation decreased. Fludarabine dosage: 63 MG DAILY IV DRIP. During the same period patient was treated with MELPHALAN, CAMPATH. Patient was hospitalized. Patient recovered.


Fludarabine Side Effects Report #5505253-4
Fludarabine side effect was reported by a Physician from GERMANY on Oct 17, 2007. Female patient, 70 years of age, was treated with Fludarabine. After drug was administered, patient experienced the following side effects: disease progression, epstein-barr virus infection, fatigue, lung infiltration, lymphoproliferative disorder, multi-organ failure, necrosis. Fludarabine dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, EVEROLIMUS. Patient was hospitalized. Patient died.